Document is current
Any future updates will be listed below
-
Authors
Riguet, Nathan http://orcid.org/0000-0002-5073-8084
Mahul-Mellier, Anne-Laure
Maharjan, Niran
Burtscher, Johannes http://orcid.org/0000-0002-2889-0151
Croisier, Marie
Knott, Graham http://orcid.org/0000-0002-2956-9052
Hastings, Janna
Patin, Alice
Reiterer, Veronika
Farhan, Hesso
Nasarov, Sergey
Lashuel, Hilal A. http://orcid.org/0000-0001-7682-8320
-
Funding
Funding for this research was provided by:
CHDI Foundation
- License Information
-
More Information
Article History
Received: 27 July 2020
Accepted: 11 October 2021
First Online: 12 November 2021
Competing interests
: H.A.L has received funding from the industry to support research on neurodegenerative diseases, including from Merck Serono, UCB, and Abbvie. These companies had no specific role in the conceptualization, preparation, and decision to publish this work. H.A.L is also the co-founder and Chief Scientific Officer of ND BioSciences SA, a company that develops diagnostics and treatments for neurodegenerative diseases based on platforms that reproduce the complexity and diversity of proteins implicated in neurodegenerative diseases and their pathologies. All other authors declare no competing interests.
